查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1338938

超級崩解劑市場、份額、規模、趨勢、行業分析報告：按產品；按劑型；按治療領域；按地區；細分市場預測，2023-2032

Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球超級崩解劑市場規模預計將達到8.2954億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

心血管疾病、糖尿病和癌症等慢性疾病的盛行率不斷上升，增加了對藥物的需求。 超級崩解劑在這些藥物的配方中發揮重要作用，並已成為製藥業的重要成分。 非傳染性疾病(NCD) 每年造成的死亡人數最多，為1,790 萬人，其次是心血管疾病（930 萬人）、慢性呼吸道疾病（410 萬人）和糖尿病（120 萬人）（200 萬人，其中包括腎病死亡） 。 這可能是未來幾年市場成長的驅動力。

技術進步正在推動新型、更有效率的超級崩解劑的開發。 例如，最近的研究調查了香蕉粉作為過量崩解劑在各種藥物製劑（包括片劑和膠囊）中的使用。 這導致這些賦形劑在多種藥品配方中的使用增加。 仿製藥的需求量很大，因為它們價格實惠且容易獲得。

超級崩解劑在製藥業中的使用不斷增加，以及新的創新解決方案的專利申請數量不斷增加，正在推動超級崩解劑市場的成長。 根據美國國家標準技術研究院（NIST）和聯合國專利商標局（USPTO）的綜合數據，N-乙烯基□咯烷酮+澱粉羥乙酸鈉有15項專利，其次是直鏈澱粉14項。 隨著製藥商尋求開發更有效率、更有效的藥物輸送系統，這一趨勢預計將持續下去。

超級崩解劑市場報告亮點

由於對快速溶解劑型的需求不斷增加，交聚維酮領域預計將會成長。

片劑是製藥業最常用的劑型，由於超級崩解劑是片劑配方的關鍵成分，因此片劑產業呈現出最高的成長率。

由於胃腸道疾病盛行率不斷增加以及對以患者為中心的藥物輸送的日益關注，預計胃腸道疾病將呈現顯著增長。

由於慢性病盛行率顯著增加和技術進步，預計北美將佔據最大的銷售份額。

由於中國和印度等發展中國家製藥業的成長，預計亞太地區未來幾年將呈現強勁的成長速度。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章全球超級崩解劑市場洞察

  • 超級崩解劑市場 - 治療領域概況
  • 超級崩解劑市場動態
    • 推動者和機會
      • 口腔崩解片越來越受歡迎
      • 不斷成長的仿製藥市場
    • 抑制因素和挑戰
      • 安全性和品質問題
  • PESTEL 分析
  • 超級崩解劑市場治療領域的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球超級崩解劑市場（按產品）

  • 主要發現
  • 簡介
  • 加工澱粉
  • 改性纖維素
  • 交聚維酮
  • 離子交換樹脂

第六章全球超級崩解劑市場，以劑型

  • 主要發現
  • 簡介
  • 平板電腦
  • 膠囊

第 7 章全球超級崩解劑市場，依治療領域劃分

  • 主要發現
  • 簡介
  • 消化系統疾病
  • 神經系統疾病
  • 腫瘤學
  • 傳染病
  • 心血管疾病
  • 血液疾病
  • 發炎性疾病

第 8 章全球超級崩解劑市場（按地區）

  • 主要發現
  • 簡介
    • 超級崩解劑市場評估，地區，2019-2032 年
  • 超崩解劑市場 - 北美
    • 北美：超級崩解劑市場（按產品），2019-2032 年
    • 北美：超級崩解劑市場，依治療領域劃分，2019-2032 年
    • 北美：超級崩解劑市場（按劑型），2019-2032 年
    • 超崩解劑市場 - 美國
    • 超級崩解劑市場 - 加拿大
  • 超級崩解劑市場 - 歐洲
    • 歐洲：超級崩解劑市場（按產品），2019-2032 年
    • 歐洲：超級崩解劑市場，依治療領域劃分，2019-2032 年
    • 歐洲：超級崩解劑市場（按劑型），2019-2032 年
    • 超級崩解劑市場 - 英國
    • 超崩解劑市場 - 法國
    • 超崩解劑市場 - 德國
    • 超崩解劑市場 - 義大利
    • 超級崩解劑市場 - 西班牙
    • 超崩解劑市場 - 荷蘭
    • 超級崩解劑市場 - 俄羅斯
  • 超級崩解劑市場 - 亞太地區
    • 亞太地區：超級崩解劑市場（按產品），2019-2032 年
    • 亞太地區：超級崩解劑市場，依治療領域劃分，2019-2032 年
    • 亞太地區：超級崩解劑市場，按劑型，2019-2032 年
    • 超崩解劑市場 - 中國
    • 超級崩解劑市場 - 印度
    • 超崩解劑市場 - 馬來西亞
    • 超崩解劑市場 - 日本
    • 超級崩解劑市場 - 印度尼西亞
    • 超崩解劑市場 - 韓國
  • 超級崩解劑市場 - 中東和非洲
    • 中東和非洲：超級崩解劑市場（按產品），2019-2032 年
    • 中東與非洲：超級崩解劑市場，依治療領域劃分，2019-2032 年
    • 中東和非洲：超級崩解劑市場，按劑型，2019-2032 年
    • 超崩解劑市場 - 沙烏地阿拉伯
    • 超級崩解劑市場 - 阿拉伯聯合大公國
    • 超崩解劑市場 - 以色列
    • 超崩解劑市場 - 南非
  • 超級崩解劑市場 - 拉丁美洲
    • 拉丁美洲：超級崩解劑市場（按產品），2019-2032 年
    • 拉丁美洲：超級崩解劑市場，依治療領域劃分，2019-2032 年
    • 拉丁美洲：超級崩解劑市場（按劑型），2019-2032 年
    • 超崩解劑市場 - 墨西哥
    • 超級崩解劑市場 - 巴西
    • 超崩解劑市場 - 阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第十章公司簡介

  • BASF
  • Roquette Freres
  • Ashland Global
  • Dow DuPont
  • DFE Pharma
  • Asahi Kasei
  • Merck
  • Corel Pharma & Avantor Performance.
Product Code: PM3382

The global superdisintegrants market size is expected to reach USD 829.54 million by 2032, according to a new study by Polaris Market Research. The report "Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer has increased the demand for drugs. Superdisintegrants play a vital role in formulating these drugs, making them essential components in the pharmaceutical industry. The most non-communicable disease deaths (NCD), 17.9 million per year, are caused by cardiovascular diseases, followed by cancer (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (1.2 million) (2.0 million, including fatalities from renal disease brought on by diabetes)). This will drive the growth of the market in the upcoming years.

Advancements in technology have led to the development of new and more efficient super disintegrants. For instance, recent studies have investigated using banana powder as a super disintegrant in various pharmaceutical formulations, including tablets and capsules. This has led to increased use of these excipients in formulating multiple drugs. The demand for generic drugs is rising due to their affordability and accessibility.

The increasing use of super disintegrants in the pharmaceutical industry, coupled with the growing number of patents being filed for new and innovative solutions, is driving the growth of the super disintegrants market. According to the combination of data from the National Institute of Standards & Technology (NIST) and the United Nations Patent and Trademark Office (USPTO), N-Vinyl pyrrolidone+sodium starch glycolate has 15 patents, followed by Amylose with 14 patents. This trend is expected to continue in the coming years as drug manufacturers seek to develop more efficient and effective drug delivery systems.

Superdisintegrants Market Report Highlights

Crospovidone segment is anticipated to grow due to increasing demand for fast dissolving dosage forms.

Tablets segment is registered the highest growth rate owing to the as tablets are the most used dosage form in the pharmaceutical industry and superdisintegrants are critical ingredients in tablet formulations.

Gastrointestinal diseases are projected to experience significant growth rate due to the growing incidence of GI disorders and increased focus on patient-centric drug delivery.

North America is expected to have the largest revenue share owing to the strong increasing incidence of chronic diseases and technological advancements.

APAC is projected to witness significant growth rate in the coming years due to the growing pharmaceutical industry in developing countries like China and India.

The global players include: BASF, Ashland Global, Dow DuPont, Roquette Freres, DFE Pharma, JRS PHARMA, Asahi Kasei, Merck, Corel Pharma & Avantor Performance.

Polaris Market Research has segmented the superdisintegrants market report based on product, formulation, therapeutic area, and region:

Superdisintegrants, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Modified Starch
  • Modified Cellulose
  • Crospovidone
  • Ion Exchange Resin

Superdisintegrants, Formulation Outlook (Revenue - USD Million, 2019 - 2032)

  • Tablets
  • Capsules

Superdisintegrants, Therapeutic area Outlook (Revenue - USD Million, 2019 - 2032)

  • Gastrointestinal Diseases
  • Neurological Diseases
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Hematological Diseases
  • Inflammatory Diseases

Superdisintegrants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Superdisintegrants Market Insights

  • 4.1. Superdisintegrants Market - Therapeutic Area Snapshot
  • 4.2. Superdisintegrants Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Adoption of Orally Disintegrating Tablets
      • 4.2.1.2. Growing Generics Market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Safety and Quality Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Superdisintegrants Market Therapeutic Area Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Superdisintegrants Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • 5.3. Modified Starch
    • 5.3.1. Global Superdisintegrants Market, by Modified Starch, by Region, 2019-2032 (USD Million)
  • 5.4. Modified Cellulose
    • 5.4.1. Global Superdisintegrants Market, by Modified Cellulose, by Region, 2019-2032 (USD Million)
  • 5.5. Crospovidone
    • 5.5.1. Global Superdisintegrants Market, by Crospovidone, by Region, 2019-2032 (USD Million)
  • 5.6. Ion Exchange Resin
    • 5.6.1. Global Superdisintegrants Market, by Ion Exchange Resin, by Region, 2019-2032 (USD Million)

6. Global Superdisintegrants Market, by Formulation

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 6.3. Tablets
    • 6.3.1. Global Superdisintegrants Market, by Tablets by Region, 2019-2032 (USD Million)
  • 6.4. Capsules
    • 6.4.1. Global Superdisintegrants Market, by Capsules, by Region, 2019-2032 (USD Million)

7. Global Superdisintegrants Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • 7.3. Gastrointestinal Diseases
    • 7.3.1. Global Superdisintegrants Market, by Gastrointestinal Diseases, By Region, 2019-2032 (USD Million)
  • 7.4. Neurological Diseases
    • 7.4.1. Global Superdisintegrants Market, by Neurological Diseases, By Region, 2019-2032 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Global Superdisintegrants Market, by Oncology, By Region, 2019-2032 (USD Million)
  • 7.6. Infectious Diseases
    • 7.6.1. Global Superdisintegrants Market, by Infectious Diseases, By Region, 2019-2032 (USD Million)
  • 7.7. Cardiovascular Diseases
    • 7.7.1. Global Superdisintegrants Market, by Cardiovascular Diseases, By Region, 2019-2032 (USD Million)
  • 7.8. Hematological Diseases
    • 7.8.1. Global Superdisintegrants Market, by Hematological Diseases, By Region, 2019-2032 (USD Million)
  • 7.9. Inflammatory Diseases
    • 7.9.1. Global Superdisintegrants Market, by Inflammatory Diseases, By Region, 2019-2032 (USD Million)

8. Global Superdisintegrants Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Superdisintegrants Market - North America
    • 8.3.1. North America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.3.2. North America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.3.3. North America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.3.4. Superdisintegrants Market - U.S.
      • 8.3.4.1. U.S.: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.3.5. Superdisintegrants Market - Canada
      • 8.3.5.1. Canada: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.4. Superdisintegrants Market - Europe
    • 8.4.1. Europe: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.4.3. Europe: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.4. Superdisintegrants Market - UK
      • 8.4.4.1. UK: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.5. Superdisintegrants Market - France
      • 8.4.5.1. France: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.5.3. France: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.6. Superdisintegrants Market - Germany
      • 8.4.6.1. Germany: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.7. Superdisintegrants Market - Italy
      • 8.4.7.1. Italy: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.8. Superdisintegrants Market - Spain
      • 8.4.8.1. Spain: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.9. Superdisintegrants Market - Netherlands
      • 8.4.9.1. Netherlands: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.10. Superdisintegrants Market - Russia
      • 8.4.10.1. Russia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.5. Superdisintegrants Market - Asia Pacific
    • 8.5.1. Asia Pacific: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.4. Superdisintegrants Market - China
      • 8.5.4.1. China: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.4.3. China: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.5. Superdisintegrants Market - India
      • 8.5.5.1. India: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.5.3. India: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.6. Superdisintegrants Market - Malaysia
      • 8.5.6.1. Malaysia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.7. Superdisintegrants Market - Japan
      • 8.5.7.1. Japan: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.8. Superdisintegrants Market - Indonesia
      • 8.5.8.1. Indonesia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.9. Superdisintegrants Market - South Korea
      • 8.5.9.1. South Korea: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.6. Superdisintegrants Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.4. Superdisintegrants Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.5. Superdisintegrants Market - UAE
      • 8.6.5.1. UAE: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.6. Superdisintegrants Market - Israel
      • 8.6.6.1. Israel: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.7. Superdisintegrants Market - South Africa
      • 8.6.7.1. South Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.7. Superdisintegrants Market - Latin America
    • 8.7.1. Latin America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.4. Superdisintegrants Market - Mexico
      • 8.7.4.1. Mexico: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.5. Superdisintegrants Market - Brazil
      • 8.7.5.1. Brazil: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.6. Superdisintegrants Market - Argentina
      • 8.7.6.1. Argentina: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. BASF
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Roquette Freres
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Ashland Global
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dow DuPont
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. DFE Pharma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Asahi Kasei
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Corel Pharma & Avantor Performance.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development

List of Tables

  • Table 1 Global Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 2 Global Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 3 Global Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 4 Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 6 North America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 7 North America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 8 U.S.: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 9 U.S.: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 10 U.S.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 11 Canada: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 12 Canada: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 13 Canada: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 14 Europe: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 15 Europe: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 16 Europe: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 17 UK: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 18 UK: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 19 UK: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 20 France: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 21 France: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 22 France: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 23 Germany: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 24 Germany: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 25 Germany: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 26 Italy: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 27 Italy: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 28 Italy: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 29 Spain: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 30 Spain: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 31 Spain: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 32 Netherlands: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 33 Netherlands: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 34 Netherlands: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 35 Russia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 36 Russia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 37 Russia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 41 China: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 42 China: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 43 China: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 44 India: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 45 India: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 46 India: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 47 Malaysia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 48 Malaysia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 49 Malaysia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 50 Japan: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 51 Japan: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 52 Japan: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 53 Indonesia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 54 Indonesia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 55 Indonesia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 56 South Korea: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 57 South Korea: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 58 South Korea: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 65 UAE: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 66 UAE: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 67 UAE: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 68 Israel: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 69 Israel: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 70 Israel: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 71 South Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 72 South Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 73 South Africa: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 74 Latin America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 75 Latin America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 76 Latin America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 77 Mexico: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 78 Mexico: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 79 Mexico: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 80 Brazil: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 81 Brazil: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 82 Brazil: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 83 Argentina: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 84 Argentina: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 85 Argentina: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Superdisintegrants Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Formulation
  • Figure 7. Global Superdisintegrants Market, by Formulation, 2022 & 2032 (USD Million)
  • Figure 8. Market by Product
  • Figure 9. Global Superdisintegrants Market, by Product, 2022 & 2032 (USD Million)
  • Figure 10. Market by Therapeutic Area
  • Figure 11. Global Superdisintegrants Market, by Therapeutic Area, 2022 & 2032 (USD Million)
  • Figure 12. Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Superdisintegrants Market